Related Experiment Video
Updated: Jan 7, 2026

Murine Model of Intestinal Ischemia-reperfusion Injury
Published on: May 11, 2016
Lactobacillus amplifies DHAMaR1 conversion to attenuate intestinal ischemia-reperfusion injury via decreasing
Tong Li1, Hongxing Cai1, Chenghao Qiu1
1Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Maresin1 (MaR1) and its precursor DHA protect against intestinal injury by inhibiting RORα-driven pyroptosis. Combining DHA with Lactobacillus offers synergistic benefits, highlighting a novel host-microbe interaction for treating ischemic injury.
Area of Science:
- Gastroenterology
- Inflammation research
- Microbiome research
Background:
- Maresin1 (MaR1), a docosahexaenoic acid (DHA)-derived mediator, has anti-inflammatory and cytoprotective properties.
- The precise role and mechanisms of MaR1 in intestinal ischemia-reperfusion (I/R) injury require further elucidation.
Purpose of the Study:
- To investigate the therapeutic potential and underlying mechanisms of MaR1 in a murine model of intestinal I/R injury.
- To explore the impact of DHA and Lactobacillus supplementation, individually and in combination, on intestinal I/R injury.
Main Methods:
- Established a murine model of intestinal I/R injury.
- Utilized knockout mice for Retinoic acid receptor-related orphan receptor alpha (RORα) and gasdermin D (GSDMD) to study signaling pathways.
- Administered MaR1 or supplemented with DHA and/or Lactobacillus, assessing intestinal injury, inflammation, and pyroptosis.
- Employed multi-omics approaches (16S rRNA sequencing, transcriptomics, metabolomics) to analyze host-microbe interactions.
Main Results:
- MaR1 administration significantly reduced epithelial injury and pyroptosis, dependent on RORα and GSDMD.
- Dietary DHA supplementation increased systemic MaR1 levels and conferred protection against I/R injury.
- Combined DHA and Lactobacillus supplementation demonstrated synergistic protective effects, with Lactobacillus enhancing DHA-to-MaR1 conversion.
- Multi-omics analyses revealed coordinated regulation of inflammatory pathways and microbial metabolic activity.
Conclusions:
- MaR1 and DHA provide significant protection against intestinal I/R injury by suppressing RORα-mediated pyroptosis.
- Probiotic-enhanced MaR1 biosynthesis represents a novel crosstalk between microbiota and lipid mediators with therapeutic implications.
- Combination therapies targeting host-microbe interactions offer a promising strategy for managing ischemic intestinal injury.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
11:04Author Spotlight: Methods for Electroporation and Transformation Confirmation in Limosilactobacillus reuteri DSM20016
Published on: June 23, 2023